More than 40 CEOs urge 45 countries to lift HIV travel restrictions

In a joint initiative headed by GBC Health, UNAIDS, and Levis Strauss & Co., more than 40 CEOs have signed a pledge urging 45 countries to repeal policies and laws restricting travel for people living with HIV, TakePart.com reports (Doheny, 11/28). "CEOs oppose HIV travel restrictions because they are discriminatory and because to succeed in today's globalized economy, companies must be able to send their employees and best talent overseas, regardless of their HIV status," according to a joint press release. Forty-five countries, including key hubs for international business, "still deny entry, stay, residence or work visas for people living with HIV," the press release notes (11/28). Restrictions in some countries "also include denial of work visas, disallowing short-term stays for business trips or conferences, and blocking longer-term stays, such as residence-for-work relocations and study-abroad programs, according to UNAIDS," the U.N. News Centre writes (11/28).

As part of the initiative, a full-page ad (.pdf) in the Financial Times states, "These obsolete laws are holdovers from the 1980s, when ignorance, prejudice and fear surrounded HIV transmission. They are unnecessary and unjust, but also unwise. HIV travel laws impede commerce, making them bad for humanity and for the bottom line. To end such backward policies once and for all, we are asking CEOs in the global business community to take a stand and call on countries to end these restrictions" (11/29). Some companies whose CEOs signed the pledge include Levi Strauss & Co., Aetna, Johnson & Johnson, The Coca-Cola Company, Pfizer, Heineken, Merck, the National Basketball Association, Kenya Airways, and Thomson Reuters, the U.N. News Centre notes (11/28).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

 

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New insights into the mechanisms of efavirenz-induced neurotoxicity